NCT03278548已完成4 期
Prospective, Randomized, Controlled, Double-blind, Multi-centre, Multinational Study on the Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery
适应症
干预措施
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 2,289
- 试验地点
- 61
- 主要终点
- Difference in mean estimated glomerular filtration rate (eGFR) (calculated from highest cystatin-C levels measured during post-operative days 1-3 (POD 1-3)) between the two treatment groups
研究概览
简要总结
The aim of the study is to investigate the safety of a 6% HES (Hydroxyethyl Starch) solution (Volulyte 6%) versus an electrolyte solution (Ionolyte) in patients undergoing elective abdominal surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 41 Years 至 85 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Ionolyte
Active Comparator
Ionolyte solution for infusion
干预措施: Ionolyte (Drug)
Volulyte 6%
Experimental
Volulyte 6% solution for infusion
干预措施: Volulyte 6% (Drug)
结局指标
主要结局
Difference in mean estimated glomerular filtration rate (eGFR) (calculated from highest cystatin-C levels measured during post-operative days 1-3 (POD 1-3)) between the two treatment groups
时间窗: post-operative days 1-3
次要结局
- Major post-operative complications(until post-operative day 90)
- Mortality(1 year)
- Composite of mortality and major post-operative complications (including renal)(until post-operative day 90)
- Total volume of administered investigational product(until 24 hours after investigational product treatment start)
- Fluid balance [Sum of volume of all intravenous medication (including investigational product and blood products) minus sum of volume of urine output (if available), drainage and estimated intra-operative blood loss](until post-operative day 3)
- Heart Rate(until post-operative day 3)
- Renal function(until 1 year after surgery)
- Calculated red blood cell (RBC) loss(on post-operative day 3)
- Inflammation(until post-operative day 1)
- Estimated intra-operative blood loss(end of surgery)
- Coagulation(until post-operative day 1)
- Adverse events(until post-operative day 90)
- Body temperature(until post-operative day 3)
- Mean arterial pressure(until post-operative day 3, if available)
- Systolic arterial blood pressure(until end of surgery)
- Diastolic arterial blood pressure(until end of surgery)
- Central venous pressure (if available)(until end of surgery)
- Haemodynamics readings as required to determine volume responsiveness [at least one parameter (stroke volume, stroke volume variation, stroke volume index, pulse pressure variation, mean arterial pressure) has to be used to guide volume administration](until 24 hours after investigational product treatment start)
- Partial pressure of carbon dioxide(until end of surgery)
- Partial pressure of oxygen(until end of surgery)
- Bicarbonate(until end of surgery)
- Arterial oxygen saturation(until end of surgery)
- Haemoglobin(until post-operative day 3)
- Haematocrit(until post-operative day 3)
- pH(until end of surgery)
- Base Excess(until end of surgery)
- Lactate(until post-operative day 3)
- Central venous oxygen saturation (if available)(until post-operative day 1)
- Serum sodium(until post-operative day 1)
- Serum potassium(until post-operative day 1)
- Serum calcium(until post-operative day 1)
- Serum chloride(until post-operative day 1)
- Length of stay in the hospital/intensive care unit(until post-operative day 90)
- Hours on mechanical ventilation(until post-operative day 7)
研究者
研究点 (61)
Loading locations...
相似试验
已完成
4 期
Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma PatientsHypovolemia Due to Acute Blood LossNCT03338218Fresenius Kabi238
已完成
3 期
Trial of 6% HES130/0.4HypovolemiaHemorrhageNCT01010022Fresenius Kabi Japan64
已完成
3 期
To assess the effect of hydroxyethyl starch(HES) solution in prolonging the duration of pain relief for hernia repair in children after inguinal nerve block and wound infiltration.CTRI/2022/11/047157All India Institute of Medical Sciences50
进行中(未招募)
不适用
Efficacy and safety of 6 % hydroxyethyl starch 130/0.4 (Voluven®) vs. 5% HSA in volume replacement therapy during elective open-heart surgery in paediatric patientsVolume replacement therapy during elective open-heart surgery in paediatric patientsMedDRA version: 9.1Level: LLTClassification code 10048935Term: Open heart surgeryEUCTR2008-006749-18-BEFresenius Kabi Deutschland GmbH60
进行中(未招募)
不适用
Efficacy and safety of 6 % hydroxyethyl starch 130/0.4 (Voluven®) vs. 5% HSA in volume replacement therapy during elective open-heart surgery in paediatric patientsVolume replacement therapy during elective open-heart surgery in paediatric patientsMedDRA version: 9.1Level: LLTClassification code 10048935Term: Open heart surgeryEUCTR2008-006749-18-ATFresenius Kabi Deutschland GmbH60
